Mesoblast Ltd
XMUN:LWB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Mesoblast Ltd
XMUN:LWB
|
AU |
|
B
|
Brooker Group PCL
SET:BTC
|
TH |
|
Opmobility SE
PAR:OPM
|
FR |
|
Etruscus Resources Corp
F:ERR
|
CA |
|
J
|
JD Food PCL
SET:JDF
|
TH |
|
B
|
Bangkok Asset Intergroup PCL
SET:BKA
|
TH |
|
E
|
ECGI Holdings Inc
OTC:ECGI
|
CA |
|
Sulzer AG
SIX:SUN
|
CH |
|
C
|
Coloseum Holding as
PSE:COLOS
|
CZ |
|
B
|
Bioscience Animal Health PCL
SET:BIS
|
TH |
|
D
|
Daiwa Securities Group Inc
OTC:DSECF
|
JP |
|
Genesis AI Corp
F:7JY
|
CA |
|
A
|
Advice IT Infinite PCL
SET:ADVICE
|
TH |
|
J
|
Juventus FC SpA
PSE:JUVE
|
IT |
|
Volta Metals Ltd
F:D0W
|
CA |
|
A
|
Astra Graphia Tbk PT
XMUN:IUA
|
ID |
|
C
|
Cascade Copper Corp
F:91O
|
CA |
|
G
|
Glenstar Minerals Inc
CNSX:GSTR
|
CA |
|
C
|
Copperwired PCL
SET:CPW
|
TH |
|
Astra International Tbk PT
F:ASJA
|
ID |
|
A
|
Assetwise PCL
SET:ASW
|
TH |
|
D
|
Doosan Skoda Power as
PSE:DSPW
|
CZ |
Bankruptcy Probability
Mesoblast Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Mesoblast Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
Mesoblast Ltd
ASX:MSB
|
2.6B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
496.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
225.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
186.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
128.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
85.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
57.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
44.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
41.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Mesoblast Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Mesoblast Ltd has total debt of 113.7m USD. This includes both short-term (0 USD) and long-term (113.7m USD) debt.
You can find a full breakdown on its Balance Sheet.